MedTrace Logo

Ghrelin Decreases Insulin Sensitivity

NCT00512525 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2009-09-09

No results posted yet for this study

Summary

Ghrelin administration increases appetite and, in rodents, induces weight gain. The aim of this study is to investigate the effect of short term ghrelin administration to humans on metabolism.

Conditions

  • Healthy Subjects

Interventions

DRUG

Ghrelin and saline (as placebo)

Intravenous infusion

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Ole Schmitz, MD · Department of Pharmacology, University of Aarhus, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2003-10-31
Completion
2003-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00512525 on ClinicalTrials.gov